US health panel loosens restrictions for controversial peptides popular online
An advisory panel of the U.S. Food and Drug Administration (FDA) has voted to loosen restrictions on controversial peptides that have become popular online but have not been adequately researched for human use.
The panel narrowly voted to allow specialty pharmacies to manufacture drugs such as BPC-157, TB-500 and KPV; This was a major regulatory hurdle to making these drugs available by prescription.
Peptides are small proteins that our bodies normally produce and have long been used to treat medical conditions, including diabetes.
But since GLP-1s (weight loss drugs) went mainstream, uncontrolled injectable peptides have exploded in the online wellness community (including many young influencers).
The FDA is not required to follow the panel’s recommendations, but it often does.
Health Secretary Robert F Kennedy has described himself as a “big fan” of drugs and has previously promised to ease restrictions on them after the Biden administration clamped down on the growing industry.
Peptides are short chains of amino acids or small proteins that our bodies produce naturally. They act as messengers that tell our cells what to do and play vital roles in our skin health, immune system and controlling our hormones.
Online influencers market peptides in “bulks” for unproven uses, claiming they can be used as a quick way to look younger and help you improve and heal your skin.
They have become popular among teens, especially men, on TikTok due to unproven claims that certain peptides can help build muscle mass and improve your body; Phrases such as “biohacking” and “loosmaxxing” have been used on some online sites to describe this trend.
Health experts have warned against drug use, citing a lack of human clinical trials and unknown long-term effects of the substances.
BPC-157 is one of the most popular peptides among wellness influencers.
It is made from stomach protein and is marketed online as being good for gut health, tissue repair and inflammation.
Its potential to aid muscle recovery has been studied in animals.
The U.S. Anti-Doping Agency (ADA) states that because it has not been extensively studied in humans, “no one knows if there is a safe dose or if there is any way to safely use this compound to treat certain medical conditions.”
The peptide is prohibited for use in sports and is considered a prohibited substance by the World Anti-Doping Agency.
KPV is also said to be good for intestinal health and tissue repair. including skin damage such as acne and to regulate the immune system.
Both were in a gray area when it came to regulation. These are not illegal to buy or possess and are widely available online, but they are not approved for human use, so they are not subject to the quality controls that regulate drug production.
Panel member Elizabeth Rebello, a pharmacist and anesthesiologist, told the committee she voted no on BPC-157 “due to a lack of efficacy data” and “safety concerns,” Reuters news agency reported.
It was reported that those who voted yes cited “the good of the majority” and “medical freedom” as the reasons for their decision.
The panel, which will continue negotiations on Friday, includes many people working in clinics or businesses selling peptides.
BPC-157 and KPV are among seven peptides the panel is considering lifting restrictions and allowing compounding pharmacies to produce that mix drugs not available from standard drug manufacturers.
Peptide restrictions were imposed during the Biden administration after FDA officials determined that the drugs did not meet safety requirements. Kennedy worked to reverse these obstacles.
